期刊文献+

干扰表皮生长因子受体磷酸化过程对乳腺癌的抑制效应

Inhibitory effect of the phosphorylation of epidermal growth factor receptor on breast cancer
原文传递
导出
摘要 目的 探讨干扰表皮生长因子受体(EGFR)的磷酸化过程对裸鼠乳腺癌移植瘤生长的影响及其作用机制.方法 建立裸鼠乳腺癌移植瘤模型,成型后随机分为Ad5-hSulf1组、Ad5-EGFP组和对照组,干预治疗后,测量计算移植瘤生长率,采用免疫组化法检测各组裸鼠移植瘤hSulf-1、EGFR和p-EGFR阳性表达,采用Western blot法检测各组裸鼠移植瘤hSulf-1、EGFR和p-EGFR蛋白表达.结果 Ad5-hSulf1组裸鼠注射治疗后第14天、21天和28天的肿瘤生长率[(165.9±23.8)%,(172.6±25.9)%,(377.3±30.5)%]明显小于同期的对照组,差异均具有统计学意义(t=12.153,21.247,14.587;P =0.000).Ad5-hSulf1组裸鼠移植瘤p-EGFR阳性表达率(46.7%)和蛋白表达[(52.7±7.4)%]明显低于Ad5-EGFR组和对照组,差异均有统计学意义(x2=8.146,t=7.384,7.587;P =0.004、0.000、0.000).结论 使用hSulf1基因抑制乳腺癌细胞的EGFR磷酸化过程,可产生明显的肿瘤抑制效应,对寻求肿瘤基因治疗的一个很有潜力的靶点具有很好的借鉴参考意义. Objective To discuss the influence of epidermal growth factor receptor (EGFR) phosphorylation on the growth of breast cancer.Methods Nude mice model of breast cancer transplantation tumor was established.Mice were randomly divided into Ad5-hSulf1 group,Ad5-EGFP group and control group.The growth rate of transplanted tumor was measured after treatment.The positive expression of hSulf-1,EGFR and p-EGFR in the nude mice were detected by immunohistochemistry,hSulf-1,EGFR and p-EGFR protein expression in the nude mice of each group was detected by blotting Western method.Results The tumor growth rate of Ad5-hSulfl group at the,21 and 28 day after transplantation [(165.9 ± 23.8) %,(172.6 ± 25.9) %,(377.3 ± 30.5) %] were significantly less than that of the control group,the difference were statistically significant(t =12.153,21.247,14.587,P =0.000).The positive expression rate (46.7%)and protein expression [(52.7 ± 7.4)%] of p-EGFR in Ad5-hSalf1 group was significantly lower than that in Ad5-EGFR group and control group.The difference were statistically significant (x2 =8.146,t =7.384,7.587,P =0.004,0.000,0.000).Conclusion To use hSulf-1 gene to inhibit the phosphorylation of EGFR in breast cancer cells can produce significant inhibitory effect on tumor.
出处 《国际免疫学杂志》 CAS 2016年第5期451-454,共4页 International Journal of Immunology
关键词 乳腺癌 表皮生长因子受体 磷酸化 hSulf1基因 Breast cancer Epidermal growth factor receptor Phosphorylation hSulf1 gene
  • 相关文献

参考文献15

  • 1张红霞,金木兰,李杰,刘敏.乳腺癌组织FAP表达病理生物学意义的研究[J].中华肿瘤防治杂志,2011,18(15):1171-1174. 被引量:8
  • 2郑荣寿,张思维,吴良有,李光琳,赵平,赫捷,陈万青.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤,2012,21(1):1-12. 被引量:564
  • 3Hem6ndez-Hem6ndez OT, Camacho-Arroyo I. Regulation of gene expression by progesterone in cancer cells: effects on cyclin D1,EGFR and VEGF [ J ]. Mini Rev Med Chem, 2013,13 ( 5 ) : 635- 642.
  • 4Sobande F, Duek L, Matjkov6 A, et al. EGFR in triple negative breast carcinoma : significance of protein expression and high gene copy number [ J]. Cesk Pato1,2015,51 ( 2 ) : 80-86.
  • 5Mitrasinovic PM. Some implications of receptor kinase signaling pathway for development of multitargeted kinase inhibitors [ J ]. Curt Radiopharm, 2013, 6 ( 1 ): 48-55.
  • 6Azzariti A, Porcelli L, Gatti G, et al. Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells [ J ]. Biochem Pharmacol, 2008,75 ( 5 ) : 1035-1044.
  • 7Brand TM, Mari I, Neha L, et al. Nuclear EGFR as a molecular tar- get in cancer[ J ]. Radiother Oncol, 2013,108 ( 3 ) : 370-377.
  • 8谢小红,顾锡冬,赵虹,胡袁媛.973例乳腺癌患病相关危险因素分析[J].中华全科医学,2014,12(6):960-962. 被引量:23
  • 9Berg M, Soreide K. EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: im- plications for targeted therapy [ J ]. Discov Med. 2012,14 ( 76 ) : 207 -214.
  • 10桂安萍,姚和瑞,凌飞海.三阴性乳腺癌细胞中上皮间质转化与EGFR单抗治疗效果的相关性[J].肿瘤防治研究,2016,43(4):249-252. 被引量:4

二级参考文献41

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:33
  • 2陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 3赵平,陈万青.2008中国肿瘤登记年报[M].北京:军事医学科学出版社.2009.13—17.
  • 4Iwasa S, Okada K, Chen WT, et al. Increased expression of se prase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer[J]. Cancer Lett, 2005,227(2):229-236.
  • 5Horak E, Smith K, Bromley L, et al. Mutant p53 EGF receptor and c-erbB-2 expression in human breast caneer[J]. Oneogene, 1991,6(12) :2277-2284.
  • 6Cooke T, Reeves J, Lannigan A, et al. The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker[J]. Eur J Cancer, 2001, 37(1): 3-10.
  • 7Ding SL, Shen LF, Yu JC, et al. Expression of estrogen receptor-alpha and Ki-67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma [J]. J Biomed Sci,2004,11(6) :911-916.
  • 8Bhatavdekar JM,Patel DD, Shah NG, et al. Prognostic significance of immunohisto -chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis[J]. Ann Surg Oncol, 2000,7(4):305-311.
  • 9Cheang MC, Chia SK, Voduc D, et al. Ki-67 index, HER2 status, and prognosis of patients with luminal B breast cancer [J]. Natl Cancer Inst, 2009, 101(10):736-750.
  • 10Curado MP,Edwards B,Shin HR,et al.Cancer Incidencein Five Continents,Vol.Ⅸ[M].IARC Scientific Publica-tions No.160,Lyon:IARC,2008.

共引文献593

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部